KR20210146318A - Cxcr4 조절인자로서 이미다졸린 유도체 - Google Patents

Cxcr4 조절인자로서 이미다졸린 유도체 Download PDF

Info

Publication number
KR20210146318A
KR20210146318A KR1020217032120A KR20217032120A KR20210146318A KR 20210146318 A KR20210146318 A KR 20210146318A KR 1020217032120 A KR1020217032120 A KR 1020217032120A KR 20217032120 A KR20217032120 A KR 20217032120A KR 20210146318 A KR20210146318 A KR 20210146318A
Authority
KR
South Korea
Prior art keywords
alkyl
methyl
thio
imidazol
thiazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020217032120A
Other languages
English (en)
Korean (ko)
Inventor
베나티아 나시마 베카두르
마티유 로데로
장-필립 헤르보발
니콜라스 피에트랑코스타
니카이아 스미스
아나이스 바레
줄리 카수
스타니슬라스 메이어
Original Assignee
유니베르시떼 드 파리
상뜨로 나쇼날 드 라 러쉐르쉐 샹띠피크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유니베르시떼 드 파리, 상뜨로 나쇼날 드 라 러쉐르쉐 샹띠피크 filed Critical 유니베르시떼 드 파리
Publication of KR20210146318A publication Critical patent/KR20210146318A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1020217032120A 2019-03-29 2020-03-27 Cxcr4 조절인자로서 이미다졸린 유도체 Ceased KR20210146318A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19305409.5 2019-03-29
EP19305409 2019-03-29
PCT/EP2020/058728 WO2020201096A1 (en) 2019-03-29 2020-03-27 Imidazoline derivatives as cxcr4 modulators

Publications (1)

Publication Number Publication Date
KR20210146318A true KR20210146318A (ko) 2021-12-03

Family

ID=66102603

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217032120A Ceased KR20210146318A (ko) 2019-03-29 2020-03-27 Cxcr4 조절인자로서 이미다졸린 유도체

Country Status (12)

Country Link
US (1) US20220144853A1 (https=)
EP (1) EP3947394A1 (https=)
JP (1) JP2022527641A (https=)
KR (1) KR20210146318A (https=)
CN (1) CN113939521A (https=)
AU (1) AU2020255206A1 (https=)
BR (1) BR112021019344A8 (https=)
CA (1) CA3132527A1 (https=)
IL (1) IL286399A (https=)
MX (1) MX2021011599A (https=)
SG (1) SG11202109671WA (https=)
WO (1) WO2020201096A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE565868A (https=) 1957-03-21
DE2348525A1 (de) 1972-09-28 1974-04-11 Searle & Co 2- eckige klammer auf 2-(2-methyl-5nitro-1-imidazolyl)-aethyl eckige klammer zu -2-thio-pseudoharnstoffe
US4205071A (en) 1976-05-14 1980-05-27 Smith Kline & French Laboratories Limited Pharmaceutical compositions having immunosuppressant activity and methods therefor
US4349674A (en) 1978-12-18 1982-09-14 American Home Products Corporation Quinoalinyl esters of carbamimidothioic acids
AR008789A1 (es) * 1996-07-31 2000-02-23 Bayer Corp Piridinas y bifenilos substituidos
US20040254221A1 (en) 2001-09-28 2004-12-16 Toru Yamazaki Novel Nitrogenous Compound and use thereof
GB0324498D0 (en) * 2003-07-21 2003-11-26 Aventis Pharma Inc Heterocyclic compounds as P2X7 ion channel blockers
CA3027296A1 (en) * 2016-06-16 2017-12-21 Centre National De La Recherche Scientifique Compounds useful for decreasing interferon level

Also Published As

Publication number Publication date
WO2020201096A1 (en) 2020-10-08
CN113939521A (zh) 2022-01-14
CA3132527A1 (en) 2020-10-08
MX2021011599A (es) 2021-12-10
BR112021019344A8 (pt) 2022-12-06
IL286399A (en) 2021-10-31
AU2020255206A1 (en) 2021-10-14
BR112021019344A2 (https=) 2021-12-14
EP3947394A1 (en) 2022-02-09
JP2022527641A (ja) 2022-06-02
US20220144853A1 (en) 2022-05-12
SG11202109671WA (en) 2021-10-28

Similar Documents

Publication Publication Date Title
US20240425477A1 (en) Ire1 small molecule inhibitors
ES2829914T3 (es) Tratamiento de enfermedades malignas de células B mediante una combinación de inhibidor de JAK y PI3K
KR102638253B1 (ko) C5a 억제제로서의 6-5 융합 고리
ES2212657T3 (es) Pirazinas sustituidas piridin-4-il o pirimidin-4-il.
IL294515A (en) Compounds bind asgpr to degrade extracellular proteins
JP6833686B2 (ja) サーチュイン調節剤としての置換架橋尿素類似体
KR101762981B1 (ko) 기분 장해 치료제
BR112019012957A2 (pt) derivados de tetra-hidroimidazo[4,5-c]piridina como indutores de internalização de pd-l1
JP2018514518A (ja) インドールアミンとしての新規５又は８−置換イミダゾ［１，５−ａ］ピリジン類、及び／又はトリプトファン２，３−ジオキシゲナーゼ
CN113620958A (zh) 用于治疗PI3K-γ介导的障碍的杂环化合物
JP2016500119A (ja) ブルトン型チロシンキナーゼ阻害剤
KR20200013720A (ko) C5a 억제제로서의 5-5 융합 고리
US20260078103A1 (en) Isoquinolones as pi3k inhibitors
US20240018125A1 (en) Cyclic isothiourea derivatives as cxcr4 modulators
CN119744260A (zh) 作为pi3k抑制剂的苯并嘧啶-4(3h)-酮
KR20210146318A (ko) Cxcr4 조절인자로서 이미다졸린 유도체
RU2701168C2 (ru) Фармацевтическая композиция, содержащая производные гидантоина
EP3691642B1 (en) [1,6]naphthyridine compounds and derivatives as cdk8/cdk19 inhibitors
US20250255878A1 (en) Small molecule inhibitors of nav1.8 sodium channels for pain relief
CN116162093A (zh) 一种tyk2抑制剂化合物及其用途
HK1173144A (en) Therapeutic agent for mood disorders
HK1173144B (en) Therapeutic agent for mood disorders

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20211006

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20221129

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20250124

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20250403

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D